BERLIN, Germany & LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK announced today the enrollment of the first patient into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) study. Drs William T. Abraham and Ralph Augostini at The Ohio State University Medical Center in Columbus, Ohio, USA, enrolled and implanted the Lumax HF-T CRT-D device in the first patients in EchoCRT. This technologically advanced cardiac device has many industry-leading features to save and enhance patients’ lives and equipped with BIOTRONIK Home Monitoring® enables wireless, automatic daily data transmission of patients’ cardiovascular and device status.
